A fluorescent tag, also known as a label or probe, is a molecule that is chemically attached to a biomolecule such as a protein, antibody, or...

With the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases. So it...

The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts...

How difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find themselves...

We previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have been...

It’s a long, hard road that begins with the identification of a promising drug candidate and ends with its introduction to the marketplace. A drug...

With the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors...

Recently, open science has been making major strides in the news. Sure, people have been clamoring for full disclosure and availability of journal...

“The $1000 Pill.” “The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make.” “A Billion a Year for Costly Drug Treatment.” These eye-catching...

In the Age of the Microbiome blog post which initiated this series we introduced the spectacular potential that the microbiome offers for drug...